A Randomized Clinical Trial of the Immunogenicity of 7-Valent Pneumococcal Conjugate Vaccine Compared to 23-Valent Polysaccharide Vaccine in Frail, Hospitalized Elderly

Long-term Comparative Immunogenicity of Protein Conjugate and Free Polysaccharide Pneumococcal Vaccines in Chronic Obstructive Pulmonary Disease

(2012) Mark T. Dransfield et al.   CLINICAL INFECTIOUS DISEASES

Pneumococcal disease in South Australia: Vaccine success but no time for complacency

(2012) David R. Johnson et al.   VACCINE

The Potential Role for Protein-Conjugate Pneumococcal Vaccine in Adults: What Is the Supporting Evidence?

(2011) D. M. Musher et al.   CLINICAL INFECTIOUS DISEASES

A Randomized Study Comparing Combined Pneumococcal Conjugate and Polysaccharide Vaccination Schedules in Adults

(2011) R. Lazarus et al.   CLINICAL INFECTIOUS DISEASES

Pneumococcal polysaccharide vaccination for adults: new perspectives for Europe

(2011) David S Fedson et al.   Expert Review of Vaccines

Serotype replacement in disease after pneumococcal vaccination

(2011) Daniel M Weinberger et al.   LANCET

Herd immunity and serotype replacement 4 years after seven-valent pneumococcal conjugate vaccination in England and Wales: an observational cohort study

(2011) Elizabeth Miller et al.   LANCET INFECTIOUS DISEASES

The 13-valent pneumococcal conjugate vaccine (PCV13) elicits cross-functional opsonophagocytic killing responses in humans to Streptococcus pneumoniae serotypes 6C and 7A

(2011) David Cooper et al.   VACCINE

The early kinetics of circulating pneumococcal-specific memory B cells following pneumococcal conjugate and plain polysaccharide vaccines in the elderly

(2010) Helen E. Baxendale et al.   VACCINE

Efficacy of pneumococcal vaccination in adults: a meta-analysis

(2009) A. Huss et al.   CANADIAN MEDICAL ASSOCIATION JOURNAL

Immunogenicity and Reactogenicity of Pneumococcal Polysaccharide and Conjugate Vaccines in Alaska Native Adults 55–70 Years of Age

(2009) Karen M. Miernyk et al.   CLINICAL INFECTIOUS DISEASES

Pneumococcal Conjugate Vaccine, Polysaccharide Vaccine, or Both for Adults? We’re Not There Yet

(2009) Katherine L. O’Brien   CLINICAL INFECTIOUS DISEASES

The Immunogenicity of 7‐Valent Pneumococcal Conjugate Vaccine versus 23‐Valent Polysaccharide Vaccine in Adults Aged 50–80 Years

(2009) David Goldblatt et al.   CLINICAL INFECTIOUS DISEASES

Sustained Reductions in Invasive Pneumococcal Disease in the Era of Conjugate Vaccine

(2009) Tamara Pilishvili et al.   JOURNAL OF INFECTIOUS DISEASES

Vaccination in the elderly: an immunological perspective

(2009) Wilbur H. Chen et al.   TRENDS IN IMMUNOLOGY

Research: The challenges of clinical trials in the exclusion zone: The case of the frail elderly

(2008) Iman Ridda et al.   AUSTRALASIAN JOURNAL ON AGEING

Biology of Immune Responses to Vaccines in Elderly Persons

(2008) Birgit Weinberger et al.   CLINICAL INFECTIOUS DISEASES

Comparison of Pneumococcal Conjugate Polysaccharide and Free Polysaccharide Vaccines in Elderly Adults: Conjugate Vaccine Elicits Improved Antibacterial Immune Responses and Immunological Memory

(2008) Andrés de Roux et al.   CLINICAL INFECTIOUS DISEASES

Initial and Subsequent Response to Pneumococcal Polysaccharide and Protein‐Conjugate Vaccines Administered Sequentially to Adults Who Have Recovered from Pneumococcal Pneumonia

(2008) Daniel M. Musher et al.   JOURNAL OF INFECTIOUS DISEASES

Phase 1 trial of 13-valent pneumococcal conjugate vaccine in Japanese adults

(2008) Daniel Scott et al.   PEDIATRICS INTERNATIONAL

Immunological responses to pneumococcal vaccine in frail older people

(2008) I. Ridda et al.   VACCINE